Delivra Health Brands Inc
OTC:DHBUF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Delivra Health Brands Inc
OTC:DHBUF
|
CA |
|
DNB Bank ASA
F:D1N
|
NO |
|
H
|
Haidilao International Holding Ltd
OTC:HDALF
|
CN |
|
R
|
Ryman Healthcare Ltd
F:RH7
|
NZ |
|
Atos SE
PAR:ATO
|
FR |
|
Danske Bank A/S
F:DSN
|
DK |
|
DWS Group GmbH & Co KgaA
F:DWS
|
DE |
|
A
|
AXA SA
DUS:AXA
|
FR |
|
Dermapharm Holding SE
OTC:DMPHF
|
DE |
|
O
|
Ooh!Media Ltd
F:0OH
|
AU |
|
EMCOR Group Inc
NYSE:EME
|
US |
|
T
|
Trinity Biotech PLC
F:TRBA
|
IE |
|
MEI Pharma Inc
NASDAQ:MEIP
|
US |
Wall St Price Targets
DHBUF Price Targets Summary
Delivra Health Brands Inc
According to Wall Street analysts, the average 1-year price target for
DHBUF is 0.3087 USD with a low forecast of 0.3057 USD and a high forecast of 0.3178 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DHBUF's stock price target?
Price Target
0.3087
USD
According to Wall Street analysts, the average 1-year price target for
DHBUF is 0.3087 USD with a low forecast of 0.3057 USD and a high forecast of 0.3178 USD.
What is the Revenue forecast for Delivra Health Brands Inc?
Projected CAGR
14%
The compound annual growth rate for Revenue over the next 2 years is 14%.